(HealthDay)—The first biosimilar to Lucentis (ranibizumab injection) has been approved for the treatment of neovascular…
View More First biosimilar approved for macular degeneration, other eye conditionsHome »
Home »
(HealthDay)—The first biosimilar to Lucentis (ranibizumab injection) has been approved for the treatment of neovascular…
View More First biosimilar approved for macular degeneration, other eye conditions